IN2013MU03843A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU03843A IN2013MU03843A IN3843MU2013A IN2013MU03843A IN 2013MU03843 A IN2013MU03843 A IN 2013MU03843A IN 3843MU2013 A IN3843MU2013 A IN 3843MU2013A IN 2013MU03843 A IN2013MU03843 A IN 2013MU03843A
- Authority
- IN
- India
- Prior art keywords
- benzyl
- methylpiperidin
- methylamine
- methanol
- pyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/98—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2015015432A MX362290B (es) | 2013-12-09 | 2014-12-02 | Un proceso mejorado para la preparacion de (3r,4r)-(1-bencilo-4-me tilpiperidina-3-il)-metilamina. |
EP19150972.8A EP3539965B1 (en) | 2013-12-09 | 2014-12-02 | An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
SI201431159T SI2994454T1 (sl) | 2013-12-09 | 2014-12-02 | Izboljšan postopek za pripravo (3R,4R)-(1-benzil-4-metil piperidin-3-il)-metil amina |
PCT/IB2014/066510 WO2015087201A1 (en) | 2013-12-09 | 2014-12-02 | An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
HUE19150972A HUE053975T2 (hu) | 2013-12-09 | 2014-12-02 | Továbbfejlesztett eljárás (3R,4R)-(1-benzil-4-metilpiperidin-3-il)-metilamin elõállítására |
TR2019/04767T TR201904767T4 (tr) | 2013-12-09 | 2014-12-02 | (3R,4R)-(1-benzil-4-metilpiperidin-3-il)-metilamin hazırlanması için geliştirilmiş bir işlem. |
PT14869304T PT2994454T (pt) | 2013-12-09 | 2014-12-02 | Um processo melhorado para a preparacao de (3r,4r)-(1-benzil-4- metilpiperidin-3-il)-metilamina |
PL14869304T PL2994454T3 (pl) | 2013-12-09 | 2014-12-02 | Ulepszony sposób wytwarzania (3R,4R)-(1-benzylo-4-metylopiperydyn-3-ylo)metyloaminy |
EP14869304.7A EP2994454B1 (en) | 2013-12-09 | 2014-12-02 | An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
PL19150972T PL3539965T3 (pl) | 2013-12-09 | 2014-12-02 | Ulepszony sposób wytwarzania (3r,4r)-(1-benzylo-4-mety-lopiperydyn-3-ylo)metyloaminy |
JP2016557204A JP6368794B2 (ja) | 2013-12-09 | 2014-12-02 | (3r,4r)−(1−ベンジル−4−メチルピペリジン−3−イル)−メチルアミンの改良された調製方法 |
BR112015025543-4A BR112015025543B1 (pt) | 2013-12-09 | 2014-12-02 | processo para a preparação de (3r,4r)-(1-benzil-4- metilpiperidina-3-il)-metilamina e compostos intermediários |
SI201431805T SI3539965T1 (sl) | 2013-12-09 | 2014-12-02 | Izboljšan postopek za pripravo (3R,4R)-(1-benzil-4-metilpiperidin-3-il)-metilamina |
US14/891,028 US9951012B2 (en) | 2013-12-09 | 2014-12-02 | Process for the preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
IN3843MU2013 IN2013MU03843A (pl) | 2013-12-09 | 2014-12-02 | |
HUE14869304A HUE042911T2 (hu) | 2013-12-09 | 2014-12-02 | Javított eljárás a (3R,4R)-(1-benzil-4-metil-piperidin-3-il)-metilamin elõállítására |
ES14869304T ES2720066T3 (es) | 2013-12-09 | 2014-12-02 | Mejora del proceso de preparación de (3R,4R)-(1-bencil-4-metilpiperidín-3-il)-metilamina |
ES19150972T ES2865058T3 (es) | 2013-12-09 | 2014-12-02 | Un proceso mejorado para la preparación de (3R,4R)-(1-bencil-4-metilpiperidin-3-il)-metilamina |
PT191509728T PT3539965T (pt) | 2013-12-09 | 2014-12-02 | Processo melhorado para a preparação de (3r,4r)-(1-benzil-4-metilpiperidin-3-il)-metilamina |
ZA2015/06551A ZA201506551B (en) | 2013-12-09 | 2015-09-04 | An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
US15/590,408 US20170240510A1 (en) | 2013-12-09 | 2017-05-09 | Process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
US15/786,195 US20180037551A1 (en) | 2013-12-09 | 2017-10-17 | Process for the Preparation of (3R,4R)-(1-BENZYL-4-METHYLPIPERIDIN-3-YL)-METHYLAMINE |
US15/868,331 US10829450B2 (en) | 2013-12-09 | 2018-01-11 | Process for the preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3843MU2013 IN2013MU03843A (pl) | 2013-12-09 | 2014-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU03843A true IN2013MU03843A (pl) | 2015-08-14 |
Family
ID=53370688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3843MU2013 IN2013MU03843A (pl) | 2013-12-09 | 2014-12-02 |
Country Status (14)
Country | Link |
---|---|
US (4) | US9951012B2 (pl) |
EP (2) | EP2994454B1 (pl) |
JP (1) | JP6368794B2 (pl) |
BR (1) | BR112015025543B1 (pl) |
ES (2) | ES2720066T3 (pl) |
HU (2) | HUE053975T2 (pl) |
IN (1) | IN2013MU03843A (pl) |
MX (1) | MX362290B (pl) |
PL (2) | PL3539965T3 (pl) |
PT (2) | PT3539965T (pl) |
SI (2) | SI3539965T1 (pl) |
TR (1) | TR201904767T4 (pl) |
WO (1) | WO2015087201A1 (pl) |
ZA (1) | ZA201506551B (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT3539965T (pt) * | 2013-12-09 | 2021-04-07 | Unichem Lab Ltd | Processo melhorado para a preparação de (3r,4r)-(1-benzil-4-metilpiperidin-3-il)-metilamina |
CA2979425C (en) | 2015-01-20 | 2020-04-14 | Wuxi Fortune Pharmaceutical Co., Ltd | Jak inhibitor |
MX370933B (es) | 2015-04-29 | 2020-01-09 | Wuxi Fortune Pharmaceuticals Co Ltd | Inhibidores jak. |
CN107531711B (zh) | 2015-05-29 | 2020-03-31 | 无锡福祈制药有限公司 | Janus激酶抑制剂 |
CN105237463B (zh) * | 2015-10-09 | 2017-10-10 | 刘卫国 | 一种(3r,4r)‑(1‑苄基‑4‑甲基哌啶‑3‑基)甲胺‑l‑二对甲苯甲酰酒石酸盐的制备方法 |
CN105884781B (zh) * | 2016-04-18 | 2018-04-20 | 山东罗欣药业集团股份有限公司 | 一种枸橼酸托法替布的制备方法 |
EP3301087A1 (en) * | 2016-09-30 | 2018-04-04 | DPx Fine Chemicals Austria GmbH & Co KG | Process for preparing chiral amines |
CN107056681B (zh) * | 2017-03-30 | 2019-10-01 | 广州白云山光华制药股份有限公司 | 一种托法替布中间体的制备方法 |
CN110668995A (zh) * | 2018-07-03 | 2020-01-10 | 江苏海悦康医药科技有限公司 | 一种枸橼酸托法替布中间体及枸橼酸托法替布的制备方法 |
CN114685515A (zh) * | 2022-03-15 | 2022-07-01 | 上海蓝乐鸟实业有限公司 | 一种托法替尼的制备方法 |
CN115872923B (zh) * | 2022-12-29 | 2023-04-28 | 成都泰和伟业生物科技有限公司 | 一种化合物及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06145144A (ja) | 1992-11-04 | 1994-05-24 | Ihara Chem Ind Co Ltd | 新規な3−アミノピリジン誘導体第4級アンモニウム塩及びこれを有効成分とする抗癌剤 |
JP4671079B2 (ja) * | 1999-07-05 | 2011-04-13 | 日本農薬株式会社 | フタラミド誘導体、その中間体及び農園芸用殺虫剤並びにその使用方法 |
KR100496940B1 (ko) * | 1999-10-20 | 2005-06-23 | 다나베 세이야꾸 가부시키가이샤 | αLβ2 개재된 세포 접착 억제제 |
SK287188B6 (sk) * | 1999-12-10 | 2010-02-08 | Pfizer Products Inc. | Pyrolo [2,3-d]pyrimidínová zlúčenina, jej použitie a farmaceutická kompozícia alebo kombinácia s jej obsahom |
HU230382B1 (hu) | 2001-02-24 | 2016-03-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xantinszármazékok, előállításuk és alkalmazásuk gyógyszerként |
US7301023B2 (en) | 2001-05-31 | 2007-11-27 | Pfizer Inc. | Chiral salt resolution |
GT200200234A (es) * | 2001-12-06 | 2003-06-27 | Compuestos cristalinos novedosos | |
CN101128454A (zh) * | 2004-12-22 | 2008-02-20 | 阿斯利康(瑞典)有限公司 | 用作抗癌药物的吡啶羧酰胺衍生物 |
SI1913000T1 (sl) * | 2005-07-29 | 2012-02-29 | Pfizer Prod Inc | Derivati pirolo(2,3-d)pirimidina; njihovi intermediati in sinteza |
WO2008029237A2 (en) * | 2006-09-05 | 2008-03-13 | Pfizer Products Inc. | Combination therapies for rheumatoid arthritis |
AU2009276420A1 (en) * | 2008-08-01 | 2010-02-04 | Biocryst Pharmaceuticals, Inc. | Piperidine derivatives as JAK3 inhibitors |
CN102395589A (zh) | 2009-04-14 | 2012-03-28 | 安斯泰来制药株式会社 | 稠合吡咯并吡啶衍生物 |
KR20130009577A (ko) * | 2009-04-20 | 2013-01-23 | 오스펙스 파마슈티컬즈 엘엘씨 | 야누스 키나아제 3의 피페리딘 억제제 |
AU2010276215A1 (en) * | 2009-07-21 | 2012-02-16 | Auckland Uniservices Limited | Heteroaryl benzamides, compositions and methods of use |
EP2483254B1 (en) * | 2009-09-29 | 2014-08-13 | Glaxo Group Limited | Novel compounds |
PT3539965T (pt) * | 2013-12-09 | 2021-04-07 | Unichem Lab Ltd | Processo melhorado para a preparação de (3r,4r)-(1-benzil-4-metilpiperidin-3-il)-metilamina |
-
2014
- 2014-12-02 PT PT191509728T patent/PT3539965T/pt unknown
- 2014-12-02 MX MX2015015432A patent/MX362290B/es active IP Right Grant
- 2014-12-02 US US14/891,028 patent/US9951012B2/en active Active
- 2014-12-02 WO PCT/IB2014/066510 patent/WO2015087201A1/en active Application Filing
- 2014-12-02 IN IN3843MU2013 patent/IN2013MU03843A/en unknown
- 2014-12-02 EP EP14869304.7A patent/EP2994454B1/en active Active
- 2014-12-02 SI SI201431805T patent/SI3539965T1/sl unknown
- 2014-12-02 SI SI201431159T patent/SI2994454T1/sl unknown
- 2014-12-02 HU HUE19150972A patent/HUE053975T2/hu unknown
- 2014-12-02 TR TR2019/04767T patent/TR201904767T4/tr unknown
- 2014-12-02 EP EP19150972.8A patent/EP3539965B1/en active Active
- 2014-12-02 PL PL19150972T patent/PL3539965T3/pl unknown
- 2014-12-02 JP JP2016557204A patent/JP6368794B2/ja not_active Expired - Fee Related
- 2014-12-02 PL PL14869304T patent/PL2994454T3/pl unknown
- 2014-12-02 ES ES14869304T patent/ES2720066T3/es active Active
- 2014-12-02 ES ES19150972T patent/ES2865058T3/es active Active
- 2014-12-02 PT PT14869304T patent/PT2994454T/pt unknown
- 2014-12-02 HU HUE14869304A patent/HUE042911T2/hu unknown
- 2014-12-02 BR BR112015025543-4A patent/BR112015025543B1/pt active IP Right Grant
-
2015
- 2015-09-04 ZA ZA2015/06551A patent/ZA201506551B/en unknown
-
2017
- 2017-05-09 US US15/590,408 patent/US20170240510A1/en not_active Abandoned
- 2017-10-17 US US15/786,195 patent/US20180037551A1/en not_active Abandoned
-
2018
- 2018-01-11 US US15/868,331 patent/US10829450B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US9951012B2 (en) | 2018-04-24 |
ES2720066T3 (es) | 2019-07-17 |
US20180134661A1 (en) | 2018-05-17 |
US20180037551A1 (en) | 2018-02-08 |
EP2994454A4 (en) | 2016-12-21 |
MX2015015432A (es) | 2016-03-15 |
WO2015087201A1 (en) | 2015-06-18 |
SI2994454T1 (sl) | 2019-05-31 |
PT2994454T (pt) | 2019-04-02 |
US10829450B2 (en) | 2020-11-10 |
ES2865058T3 (es) | 2021-10-14 |
EP2994454B1 (en) | 2019-03-06 |
MX362290B (es) | 2019-01-10 |
PL2994454T3 (pl) | 2019-09-30 |
PT3539965T (pt) | 2021-04-07 |
ZA201506551B (en) | 2017-02-22 |
EP3539965B1 (en) | 2021-01-20 |
BR112015025543A2 (pt) | 2017-07-18 |
PL3539965T3 (pl) | 2021-07-05 |
JP2017503007A (ja) | 2017-01-26 |
HUE053975T2 (hu) | 2021-08-30 |
EP3539965A1 (en) | 2019-09-18 |
TR201904767T4 (tr) | 2019-05-21 |
HUE042911T2 (hu) | 2019-07-29 |
EP2994454A1 (en) | 2016-03-16 |
US20170240510A1 (en) | 2017-08-24 |
BR112015025543B1 (pt) | 2020-11-03 |
US20160102057A1 (en) | 2016-04-14 |
SI3539965T1 (sl) | 2021-07-30 |
JP6368794B2 (ja) | 2018-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2013MU03843A (pl) | ||
MY156546A (en) | Process for the regioselective preparation of 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives | |
MY201120A (en) | Intermediates for use in a process of producing pyrrole compounds | |
MX2010009003A (es) | Ciclohexanodimetanamina por aminacion directa de ciclohexanodimetanol. | |
SA515361251B1 (ar) | طريقة لزيادة تكوين حمض بيرو-جلوتاميك من بروتين | |
JOP20160185B1 (ar) | طريقة لتحضير (4s)-4-(4- سيانو-2- ميثوكسي فنيل)-5- إيثوكسي-8،2-داي ميثيل-4،1-داي هيدرو-6،1- نافثيريدين-3- كربوكساميد واسترجاع (4s)-4-(4- سيانو-2- ميثوكسي فنيل)-5- إيثوكسي-8،2- داي ميثيل-4،1- داي هيدرو-6،1- نافثيريدين-3- كربوكساميد بواسطة طرق كهروكيميائية | |
WO2013121436A3 (en) | A process for preparation of rivaroxaban and intermediates thereof | |
MX2014014138A (es) | Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico. | |
WO2014057498A3 (en) | Process for the preparation of cobicistat intermediates | |
DK3342867T3 (da) | Xylanasemutant, fremgangsmåde til fremstilling og anvendelse herfor, og fremgangsmåde til fremstilling af forsukret lignocellulose | |
UA112331C2 (uk) | Композиція, що містить блок-співконденсати пропіл-функціоналізованих силіконатів і силікатів лужних металів, а також спосіб їх одержання | |
EP2463266A4 (en) | PROCESS FOR PRODUCING BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE | |
MY155284A (en) | Process for the preparation of ajoene | |
EA201200820A1 (ru) | Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов | |
UA106724C2 (uk) | Спосіб отримання заміщених піримідинових похідних | |
MX337357B (es) | Excipiente para tableteado a base de lactosa y celulosa. | |
MX2010009931A (es) | Proceso para la preparacion de 2-amino-2-[2-(4-c3-c21-alquil-fenil )-etil]-propano-1,3-dioles. | |
MY163020A (en) | A process for the preparation of etoricoxib | |
WO2011027359A3 (en) | Process for the preparation of 4 -hydroxy atomoxetine and intermediates in the manufacture thereof | |
MX356357B (es) | Metodos para producir molindona y sus sales. | |
MX2013006017A (es) | Separacion de enantiomeros derivados de triazina usando acido tartarico. | |
BR112015009139A2 (pt) | processo de produção de soforose a partir de soforolipídios | |
MX2014004847A (es) | Procedimiento para la preparacion y estabilizacion de composiciones de policarbonato modificadas al impacto usando disoluciones diluidas de compuestos acidos. | |
MX349985B (es) | Procedimiento de preparación de ésteres de fenilacetil aminoácido espirocíclicos con sustitución cis-alcoxi y derivados de 1h-pirrolidin-2,4-diona espirocicíclicos con sustitución cis-alcoxi. | |
WO2013072766A3 (en) | Process for cabazitaxel and intermediates thereof |